C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.570
+0.910 (34.21%)
At close: Sep 15, 2025, 4:00 PM EDT
3.650
+0.080 (2.24%)
After-hours: Sep 15, 2025, 5:42 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $254.08 million as of September 15, 2025. Its market cap has decreased by -43.01% in one year.
Market Cap
254.08M
Enterprise Value
55.60M
1-Year Change
-43.01%
Ranking
Category
Stock Price
$3.57
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $254.08M, a decrease of -67.12%. That is a compound annual growth rate of -20.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 189.31M | -25.50% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
| Oct 2, 2020 | 772.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 672.22B |
| Johnson & Johnson | 430.11B |
| AbbVie | 383.43B |
| UnitedHealth Group | 310.81B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.52B |